Navigation Links
Life-saving primary PCI rising in Stent for Life countries

Paris, 16 May 2012: Life saving primary percutaneous coronary intervention (PPCI) treatment is increasing in countries participating in the Stent for Life Initiative.

These achievements and other activities will be revealed at EuroPCR 2012, 15-18 May, in Paris, France. EuroPCR is the official annual meeting of the European Association for Percutaneous Cardiovascular Interventions (EAPCI), a registered branch of the European Society of Cardiology (ESC).

The Stent for Life Initiative is driving equal access to PPCI in heart attack patients across Europe. The mission is to improve the delivery of care and patient access to the life saving indications of PPCI, thereby reducing mortality and morbidity in patients suffering from acute coronary syndromes (ACS). The objective is to increase the use of PPCI to more than 70% of all ST elevation myocardial infarction (STEMI) patients, achieving PPCI rates of more than 600 per one million inhabitants a year. To do this the aim is to offer a 24/7 PCI service at all relevant facilities to cover the country population need.

"There is great progress in all Stent for Life countries where we are promoting primary PCI," says Professor Steen Kristensen (Aarhus, Denmark), Stent for Life Initiative Chair. "All countries are reporting back now that the numbers of patients treated with primary PCI, the best reperfusion therapy, is increasing."

There are two prongs to the initiative. First is to reduce delays in patients seeking treatment. That means calling an ambulance immediately when they have symptoms of a heart attack. The Stent for Life Initiative is supporting patient awareness campaigns called ACT NOW.SAVE A LIFE in several countries to promote what patients should do if they have heart attack symptoms. More information about the campaigns and their results will be available at the Stent for Life Initiative booth at EuroPCR (M58, Level 2).

Second is to reduce delays in the system so that patients who have a heart attack get reperfusion therapy, which means opening the vessel to the heart, as quickly as possible. Health systems need a straight line from the ambulance to the catheterisation laboratory where the clot can be removed with a catheter technique called primary angioplasty or PPCI. The Stent for Life Initiative promotes taking an electrocardiogram (ECG) in the ambulance so that patients can be diagnosed and directed to the correct part of the hospital.

Women have even greater delays than men in accessing lifesaving PPCI. They are often diagnosed later and may therefore not get access to reperfusion therapy in some countries. Women are more likely than men to die within a year of a heart attack and to develop heart failure.

The Stent for Life Initiative is tackling these disparities through a collaboration with Women in Innovations (WIN). WIN is a global group of female interventional cardiologists aimed at addressing gender disparities in cardiovascular care. It became an affiliated activity of the Stent for Life Initiative in March during the Stent for Life Forum 2012 in Prague. A partnership project aims to increase awareness of women and heart disease amongst doctors and patients in Europe. It will target countries with the greatest need for education in this area.

Professor Kristensen says: "For women, the delay to PPCI treatment is longer and we are collaborating with WIN to try to optimise the therapy for women with heart attacks."

The Stent for Life Initiative is holding a number of sessions at EuroPCR, including a plenary session on Thursday, 17 May on how to optimise the delivery and quality of PPCI. This will include understanding the causes of treatment delay and how to reduce it, and identifying the requirements for a successful STEMI network.


Contact: Marielle de la Torre
European Society of Cardiology

Related medicine news :

1. Chemotherapy proves life-saving for some leukemia patients who fail induction therapy
2. Life-saving radio campaign launches in Burkina Faso
3. A Life-Saving Lesson That Took Decades to Learn
4. New life-saving diagnostic test for HIV patients featured in Better World Report
5. FDA clears new IMMY and University of Nevada, Reno life-saving blood test
6. Sanitation pioneer praised by African governments for life-saving work over 3 decades
7. Nearly half of women with advanced breast cancer in the US not receiving life-saving treatment
8. Genome Scans May Reveal Life-Saving Alternatives for Cancer Patients
9. FDA approval of brain aneurysm device gives Jefferson neurosurgeons another life-saving tool
10. University of Nevada, Reno, teams with IMMY to make new life-saving blood test
11. Scripps Blood & Marrow Transplant Program Celebrates 30th Anniversary of Providing Life-Saving Care
Post Your Comments:
(Date:11/30/2015)... , ... November 30, 2015 , ... GKhair & Tibolli ... the San Juan Beauty Show held on November 8th and 9th at the Puerto ... media personalities, hair artists, renowned beauticians and top of the line fashion journalists. The ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... provider of enterprise Time and Attendance/Workforce Management cloud-based solutions, announced today that ... Program with competencies in the Application Development, demonstrating a “best-in-class” ability and ...
(Date:11/30/2015)... , ... November 30, 2015 ... ... Inc. are pleased to announce their strategic partnership at the Radiological Society ... Transcription Service, Inc., and Winscribe, global providers of cutting-edge dictation and speech-enabled ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... product dealer. Joining more than 30 HealthPostures’ dealers located throughout the United States, ... increase the number of corporate, industrial, manufacturing and government workers and organizational leaders ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... patented products, announces the Unstoppable Swappables, a household invention that provides an economical ... $2 billion a year and is growing at 2.6%," says Scott Cooper, CEO ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... DUBLIN , Nov. 27, 2015 Research ... of the "Global Intrauterine Devices Market 2015-2019" ... --> In this report, the author ... intrauterine devices market for 2015-2019. To calculate the market ... of following type of products: Hormonal IUDs and copper ...
(Date:11/26/2015)... UTRECHT , Países Bajos, November 26, 2015 /PRNewswire/ ... con la terapia fotodinámica de Bremachlorin para el cáncer ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Un nuevo enfoque combina la inmunoterapia con la ...   Clinical Cancer Research . --> ...
(Date:11/26/2015)... November 26, 2015 ... nieuwe aanpak combineert immunotherapie met Bremachlorin-photodynamische therapie ... ) --> ... (Photo: ) ... Medisch Centrum (LUMC) blijkt ...
Breaking Medicine Technology: